428440-11-3 Usage
Uses
Used in Pharmaceutical Industry:
(R)-2-TERT-BUTOXYCARBONYLAMINO-SUCCINIC ACID BIS(DIETHYL ESTER) is used as a building block for the synthesis of various pharmaceuticals due to its unique structure and functional groups, which can be utilized in the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, (R)-2-TERT-BUTOXYCARBONYLAMINO-SUCCINIC ACID BIS(DIETHYL ESTER) is used as a building block for the synthesis of agrochemicals, contributing to the development of new pesticides, herbicides, and other agricultural products.
Used in Organic Synthesis:
(R)-2-TERT-BUTOXYCARBONYLAMINO-SUCCINIC ACID BIS(DIETHYL ESTER) is used as a reagent in organic synthesis, where its unique structure and functional groups can be employed in the creation of various organic compounds and materials.
Used as a Precursor in Derivative Preparation:
(R)-2-TERT-BUTOXYCARBONYLAMINO-SUCCINIC ACID BIS(DIETHYL ESTER) is also used as a precursor in the preparation of various derivatives, further expanding its applications in different fields and industries.
Storage and Handling:
(R)-2-TERT-BUTOXYCARBONYLAMINO-SUCCINIC ACID BIS(DIETHYL ESTER) is stable under normal conditions and should be handled and stored in a dry and cool environment to maintain its properties and ensure safety during use.
Check Digit Verification of cas no
The CAS Registry Mumber 428440-11-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,8,4,4 and 0 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 428440-11:
(8*4)+(7*2)+(6*8)+(5*4)+(4*4)+(3*0)+(2*1)+(1*1)=133
133 % 10 = 3
So 428440-11-3 is a valid CAS Registry Number.
InChI:InChI=1/C13H23NO6/c1-6-18-10(15)8-9(11(16)19-7-2)14-12(17)20-13(3,4)5/h9H,6-8H2,1-5H3,(H,14,17)/t9-/m1/s1
428440-11-3Relevant articles and documents
THIADIAZOLE MODULATORS OF S1P AND METHODS OF MAKING AND USING
-
Paragraph 0142, (2017/01/26)
The invention is directed to compounds of the formula: wherein each of the variables are defined herein, as well as methods of making and using the compounds as agonists of S1P1 and/or S1P5 for instance treating an autoimmune disease.
CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
-
Page/Page column 76, (2010/11/27)
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.
CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
-
Page/Page column 266-268, (2008/06/13)
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of one or more mitotic kinesins are disclosed.